Dopamine agonists and sleep in Parkinson's disease

Neurology

Volumn 58, Issue 4 SUPPL. 1, 2002, Pages

  Cantor, Charles R ^a   Stern, Matthew B ^a  

^a Penn Neurological Institute   (United States)

Author keywords

Daytime sleepiness; Dopamine agonists; Hypocretin; Parkinson's disease; Sleep; Sudden onset sleep

Indexed keywords

ANTIDEPRESSANT AGENT; BROMOCRIPTINE; CARDIOVASCULAR AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOT DERIVATIVE; HYPNOTIC AGENT; LEVODOPA; LISURIDE; NEUROLEPTIC AGENT; PERGOLIDE; PIRIBEDIL; PLACEBO; PRAMIPEXOLE; ROPINIROLE; ANTIPARKINSON AGENT;

AGE; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; DOSE RESPONSE; DRUG EFFECT; ERYTHROMELALGIA; HALLUCINATION; HUMAN; LUNG FIBROSIS; MOTOR DYSFUNCTION; NAUSEA AND VOMITING; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; REVIEW; RISK FACTOR; SEDATION; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP WAKING CYCLE; SOMNOLENCE; CHEMICALLY INDUCED DISORDER; PHYSIOLOGY; SLEEP;

ANTIPARKINSON AGENTS; DOPAMINE; DOPAMINE AGONISTS; HUMANS; PARKINSON DISEASE; SLEEP; SLEEP DISORDERS;

EID: 0037176878     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.58.suppl_1.s71     Document Type: Review

References (55)

1. Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole
2. Pramipexole-induced somnolence and episodes of daytime sleep
3. Sleep disturbances in Parkinson's disease
4. Non-ergot dopamine agonist-induced sleep attacks
5. Sleep attacks (sleep episodes) with pergolide
6. Sleep attacks and Parkinson's disease treatment
7. Sleep episodes in Parkinson's disease: A wake-up call
8. Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders
9. Parkinsonism
10. Basic mechanisms of sleep-wake states
11. The dopaminergic system and sleep, and sleep-related involuntary movements
12. Stimulation of dopamine D-1 receptors by SKF 38393 induces EEG desynchronization and behavioral arousal
13. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations
14. Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants
15. Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: A study of D- and L-derivatives in canine narcolepsy
16. Dopaminergic role in stimulant-induced wakefulness
17. Drug-related sleep disturbances and Parkinson's disease: Effects of dopaminergic antiparkinsonian drugs on sleep and wakefulness
18. L-dopa-induced sedation: A double-blind crossover controlled study versus triazolam and placebo in healthy volunteers
19. Safety and efficacy of pramipexole in early Parkinson's disease
20. "Sleep attacks" and excessive daytime sleepiness in Parkinson disease: A survey of 200 consecutive patients
21. Daily somnolence and night sleep in Parkinson disease: Role of treatment and disease severity
22. Ropinirole-induced sedation: A randomized placebo-controlled study in healthy volunteers
23. Sleep disorders and sleep effect in Parkinson's disease
24. A community-based study of sleep disorders in patients with Parkinson's disease
25. A new method for measuring daytime sleepiness: The Epworth sleepiness scale
26. FAST TRACK: Daytime sleepiness in Parkinson's disease
27. Normal aging
28. Polysomnography of adults and elderly: Sleep architecture, respiration, and leg movement
29. Improvement of sleep architecture in PD with subthalamic nucleus stimulation
30. Hallucinations, REM sleep, and Parkinson's disease
31. Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
32. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease
33. Restless legs syndrome and periodic limb movement disorders
34. Sleep-related violence, injury and REM sleep behavior disorder in Parkinson's disease
35. Delayed emergence of a parkinsonian disorder in 38% of 29 older men originally diagnosed with idiopathic rapid eye movement sleep behavior disorder
36. REM sleep behavior disorder and degenerative dementia
37. REM sleep behavior disorder
38. Rapid eye movement sleep behaviour disorder: Demographic, clinical and laboratory findings in 93 cases
39. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa
40. Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine
41. Letter
42. Waking up to sleep episodes in Parkinson's disease
43. Parkinson's disease, part II
44. The early treatment of Parkinson's disease: Levodopa, dopamine agonists or both
45. Sleep disruption, daytime somnolence, and "sleep attacks" in Parkinson's disease: A clinical survey in PD patients and age-matched healthy volunteers
46. Daytime sleepiness and Parkinson treatment
47. Excessive daytime sleepiness and sudden onset sleep in Parkinson's disease: A survey from 18 Canadian movement disorders clinics
48. Nocturnal sleep and daytime alertness in the MPTP-treated primate
49. Juvenile Parkinson's disease with REM sleep behavior disorder, sleepiness, and daytime REM onset
50. Is excessive daytime sleepiness in Parkinson's disease really related to poor sleep quality? An objective study of 47 patients
51. Autosomal recessive early-onset parkinsonism with diurnal fluctuation: Clinicopathologic characteristics and molecular genetic identification
52. Sleep benefit in Parkinson's disease
53. Clinical correlates of sleep benefit in Parkinson's disease
54. An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines